Low
₹
High
₹
| Previous Close | |
|---|---|
| Day's Range | N/A - N/A |
| Open | |
| 52 Week Range | N/A - N/A |
| Volume |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24167.95 | 26373.20 | 22182.55 |
| Nifty IT | 28978.05 | 40301.40 | 25699.10 |
| Nifty Next 50 | 72767.15 | 73141.05 | 59896.10 |
| NIFTY50 USD Index | 8702.5 | 10443.40 | 8132.40 |
| Nifty Bank | 57858.75 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62954.35 | 63183.35 | 52032.85 |
| Nifty 500 | 23338.2 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18088.9 | 18114.45 | 14804.55 |
| Nifty 100 | 25246.45 | 26975.15 | 22720.45 |
| Nifty FMCG | 48818.75 | 58485.05 | 45334.15 |
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereto, AstraZeneca Pharma India has informed that, Bhavana Agrawal, Executive Director and Chief Financial Officer (‘CFO’) has communicated her resignation from the position of CFO (Key Managerial Personnel) of the Company with effect from the close of business hours on August 31, 2026, pursuant to her appointment to a regional role within the AstraZeneca Group. A copy of the resignation letter is enclosed as Annexure – A. Further, the details as required under the SEBI Master Circular SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as Annexure – B.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Insecticides (India) has informed that the Meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 11th day of August, 2026, to consider and approve the Unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2026. Further, with reference to the above meeting of the Board of Directors, it has already informed vide its letter dated No. IIL/SE/2026/2206/01 dated June 22, 2026 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed from July 01, 2026 till the end of 48 hours after the declaration of the Company's Un-audited financial results for the Quarter ended June 30, 2026. The above information is also being uploaded on the website of the Company at www.insecticidesindia.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of index is ₹ as of .
The total volume of index is as of .
The percentage change in value of index is % as of .
The absolute increase in index value since the previous trading day is ₹ as of .
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.